We are pleased to announce an upcoming webinar that will explore the groundbreaking field of RNA interference and its transformative potential in the realm of transplantation. The webinar is set to offer an insight starting from biological concepts and moving towards innovative clinical uses that are revolutionising the landscape of patient treatment.
Scheduled for 12 November at 17:30 CET, the webinar will feature distinguished experts in the field:
● Paulo Martins (United States) will initiate the session with an inspiring introduction, laying the groundwork for a deeper appreciation of RNA-based medicine.
● Julianna Buchwald (United States) and Anastasia Khvorova (United States) will take us through the mechanisms and therapeutic prospects of RNA interference, showcasing how these insights are being translated into meaningful clinical practice.
● Emily Thompson (United Kingdom) will discuss the impactful use of RNA interference to mitigate ischemia-reperfusion injury, a pivotal concern in transplantation.
● Anne-Laure Leclerc (France) will present a groundbreaking proof-of-concept study on isolated kidney transplantation under lumasiran therapy for primary hyperoxaluria type 1.
The event will close with an open discussion, enabling participants to engage with the speakers and reflect on the profound implications of these advancements for the future of transplantation medicine. Paulo Martins will wrap up the session with key takeaways, reinforcing the significance of our collective efforts. This webinar provides a chance to learn from professionals and get inspired by the latest advancements, in RNA based treatments, for transplantation purposes. We invite you to register and join us in this empowering session.
